Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Bone Marrow Transplantation|July 22, 1999
Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapyM B Kleinman, E L Wiley, M Guo, et al.Blood|November 1, 1983
Estrogen receptor analysis in chronic lymphocytic leukemiaS T Rosen, Z Maciorowski, F Wittlin, et al.Annals of Hematology|October 1, 1992
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup studyK B Miller, K Kim, F S Morrison, et al.Bone Marrow Transplantation|January 31, 2006
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantationS Singhal, L I Gordon, M S Tallman, et al.Blood|March 7, 1998
BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory studyJ N Winter, J Andersen, J C Reed, et al.Bone Marrow Transplantation|June 6, 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?J Mehta, L I Gordon, M S Tallman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphomaD A Macdonald, K Ding, M K Gospodarowicz, et al.Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancerM S Tallman, A W Rademaker, L Jahnke, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cellsJ N Winter, H M Lazarus, A Rademaker, et al.Pageof 6